Kyle Malady, Executive Vice President and Group CEO of Verizon’s Business unit, sold 1,100 shares of the company’s common stock on August 25 for a total of $55,066, according to a regulatory filing.
The transaction was executed under a Rule 10b5-1 trading plan adopted on May 18, 2026. Following the sale, Malady retains direct ownership of 108,766 shares and holds an additional 20,197 shares indirectly through a 401(k) plan.
Verizon’s stock closed at $50.06 on the day of the sale, near its 52-week high of $51.68. Year-to-date, the shares have gained 29.6%, supported by a dividend yield of 5.63% and 21 consecutive years of dividend increases.
The disposal follows Verizon’s second-quarter results, which showed adjusted earnings of $1.30 per share, exceeding the $1.28 forecast, though revenue of $34.3 billion fell short of the $35.28 billion consensus. The company raised its full-year guidance, citing stronger profitability and higher expected cash flow.
Analysts have responded with upward revisions: Scotiabank lifted its price target to $52.50, while Bernstein SocGen Group increased its target to $47. The stock’s performance coincides with competitive pressure from SpaceX, which is developing a full mobile service network that could challenge major U.S. telecom providers.
